Gautam Khanna, an analyst from TD Cowen, maintained the Hold rating on Leidos Holdings. The associated price target is $210.00.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Gautam Khanna has given his Hold rating due to a combination of factors influencing Leidos Holdings. The company’s recent performance in the Health and Civil sectors contributed to a strong third-quarter result, but the outlook for the fourth quarter suggests a potential decline in sales and earnings per share compared to previous expectations. This is partly due to uncertainties surrounding the volume of VA medical exams and the impact of a government shutdown, although Khanna believes the situation may not be as severe as projected.
Additionally, while there is some potential for earnings per share growth in 2026, it is not as significant as the growth seen in 2025. The company is also navigating through challenges such as the decision to not bid on certain contracts, which could impact future revenues. Despite these challenges, Leidos Holdings has a substantial pipeline of outstanding bids, which could lead to strong contract awards in the coming months. Overall, these mixed factors contribute to the Hold rating, reflecting a balanced view of potential risks and opportunities.
In another report released on November 5, UBS also maintained a Hold rating on the stock with a $216.00 price target.